Dave Lashmet is editor of Stansberry Venture, an advisory service focused on the most important trend in the world – emerging technologies. This letter takes a “venture capitalist” approach to investing… seeking out small-cap speculative stocks with strong catalysts and outstanding breakout growth potential.
Dave undertakes an intensive research process to discover under-the-radar technology and medical companies with stunning catalysts for near-term growth. The stocks recommended in the Stansberry Venture portfolio have the potential to double and triple in price. Dave’s first three picks in the Venture portfolio have more than doubled in price. (CEMP, ESPR and IPH.PA)